Aspen Aerogels (NYSE:ASPN) Receives “Buy” Rating from Roth Mkm

Aspen Aerogels (NYSE:ASPN)‘s stock had its “buy” rating reaffirmed by equities research analysts at Roth Mkm in a report released on Tuesday, Benzinga reports. They currently have a $22.00 target price on the construction company’s stock. Roth Mkm’s price target suggests a potential upside of 44.55% from the stock’s current price.

Several other research firms have also recently weighed in on ASPN. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. HC Wainwright reissued a “buy” rating and issued a $20.00 price target on shares of Aspen Aerogels in a research note on Wednesday, February 14th. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

Aspen Aerogels Stock Down 2.8 %

ASPN stock opened at $15.22 on Tuesday. The firm has a 50-day moving average of $16.42 and a two-hundred day moving average of $13.50. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $19.10. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. The company has a market cap of $1.17 billion, a price-to-earnings ratio of -23.06 and a beta of 2.04.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 19.19% and a negative return on equity of 10.47%. The business had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. During the same quarter in the prior year, the company posted ($0.20) EPS. As a group, analysts forecast that Aspen Aerogels will post -0.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently made changes to their positions in the stock. Banque Cantonale Vaudoise boosted its position in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares during the period. McAdam LLC purchased a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $191,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Aspen Aerogels by 71.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after purchasing an additional 9,601 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after purchasing an additional 3,607 shares during the period. Finally, Cornerstone Investment Partners LLC purchased a new position in shares of Aspen Aerogels during the 4th quarter worth approximately $230,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.